Results 261 to 270 of about 244,635 (318)

Histological and Immunohistochemical Characterization of a Histiocytic Sarcoma Associated With a Follicular Lymphoma in a Ring‐tailed Lemur (Lemur catta)

Veterinary Medicine and Science, Volume 12, Issue 2, March 2026.
Histological and Immunohistochemical Characterization of a Histiocytic Sarcoma Associated with a Follicular Lymphoma in a Ring‐tailed Lemur (Lemur catta). Nicolás Aradilla, Rocío Canales, Teresa Lorenzo‐Bermejo, Mireia Mainez, Jordi Aguiló‐Gisbert, David Marbella, Javier María De Pablo‐Moreno and Antonio Rodríguez‐Bertos.
Nicolás Aradilla, Rocío Canales, Teresa Lorenzo‐Bermejo, Mireia Mainez, Jordi Aguiló‐Gisbert, David Marbella, Javier María De Pablo‐Moreno, Antonio Rodríguez‐Bertos   +7 more
wiley   +1 more source

Central pontine myelinolysis in diffuse large B-cell lymphoma, a case series and literature review. [PDF]

BMC Neurol
Bakharji A, Al Hijab A, Al Harbi T, Ali EN, Almuhaish H, Eskander M, Abdulbaqi M, Bashir S, Al Thubaiti I.   +8 more
europepmc   +1 more source

What Is Your Diagnosis? Multiple Subcutaneous Lumps in a Horse

Veterinary Clinical Pathology, EarlyView.
Federica Meistro, Maria Virginia Ralletti, Riccardo Rinnovati, Alessandro Spadari, Maria Morini   +4 more
wiley   +1 more source

Safety and Efficacy of Anticoagulation Therapy in Paediatric Patients With Solid Tumours or Lymphomas at Risk of Thrombocytopenia: A Retrospective Study

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Background Patients with solid tumours or lymphomas have an increased risk of thromboembolism (TE) and thrombocytopenia. Evidence‐based strategies for anticoagulation therapy (ACT) for patients with thrombocytopenia are limited. We examined the impact of thrombocytopenia on ACT administration and bleeding incidence in children with solid ...
Andrés Felipe Fajardo, Katherine Talpin, Bishal Harry, Uma H. Athale, Anthony K. C. Chan, Mihir D. Bhatt   +5 more
wiley   +1 more source

Primary thyroid diffuse large B-cell lymphoma: fine needle aspiration and histological correlation. [PDF]

J Pathol Transl Med
Moon WS, Hong YT, Ahn AR.
europepmc   +1 more source

What to Do When Medical Evidence Can Only Be Generated Through Routine Data: An Example From Pediatric Oncology

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Children undergoing allogeneic stem cell transplantation often receive off‐label rituximab treatment for Epstein–Barr virus reactivation, using adult dosing without pediatric evidence. This project aims to develop a clinical decision support tool (CDSS) that provides evidence‐based dosing scenarios by analyzing real‐world patient data.
Birgit Burkhardt, Antje Walz, Dietrich Knoerzer   +2 more
wiley   +1 more source

Between Blood and Tumor: Retroperitoneal Hematoma Look-Alike Revealed as Diffuse Large B-Cell Lymphoma. [PDF]

Cureus
Dar UA, Zakhireh B, Hakim N, Kim B, Didia C.   +4 more
europepmc   +1 more source

Machine learning methods for predicting adverse drug events: A systematic review

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 422-444, February 2026.
Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, Sheikh S. Abdullah, Neda Rostamzadeh, Atefeh Jafari, Lujain Izzedin, Kamran Sedig, Flory T. Muanda   +8 more
wiley   +1 more source

Intravascular Large B-cell Lymphoma Presenting as Hemophagocytic Lymphohistiocytosis and Pyrexia of Unknown Origin: A Diagnostic Dilemma. [PDF]

Cureus
Aloodigothi MH, Anilkumar A, Kunhayamed A.   +2 more
europepmc   +1 more source

Bispecific Antibodies Versus Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Comparative Narrative Review of Efficacy, Safety, and Accessibility

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, and despite advances in frontline therapies such as rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone, approximately 30%–40% of patients develop relapsed or refractory (
Dana Sofian Abou, Husna Irfan Thalib, Fayza Akil, Samia Zuhair Sabbagh, Hala Sofian Abou, Mable Pereira, Fatma ElSayed Hassan   +6 more
wiley   +1 more source